EDGAR·FLOW

Guardant Health, Inc. — Form 8-K

Filed November 16, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 28/100
What the filing says
Guardant Health, Inc. issued $550 million aggregate principal amount of 0% Convertible Senior Notes due May 15, 2032, with an initial conversion rate of 4.7858 shares per $1,000 principal amount (conversion price ~$209.14/share). The notes are unsecured, bear no regular interest, and are convertible into common stock upon satisfaction of specified conditions (stock price exceeding 130% of conversion price, trading price condition, specified corporate events, redemption call, or free convertibility from Feb 15, 2032). The company may redeem the notes on or after Nov 20, 2029 if the stock price exceeds 130% of conversion price for 20+ of 30 trading days preceding the redemption notice date, or redeem all notes (cleanup redemption) if less than $50M principal remains outstanding and notes are freely tradable.
Why this rating

$550M convertible issuance is ~8.9% of Guardant's $6.2B market cap—material financing event but not transformational. No imminent dilution risk given 130% conversion premium. Routine capital raise for a mature biotech company.

View original filing on SEC.gov ↗ GH · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.